Reports for ACCORD HEALTHCARE INC
Company Name
ACCORD HEALTHCARE INC
Totals |
||
Shortage reports |
313 |
|
| Actual shortage: | 57 (18%) | |
| Anticipated shortage: | 13 (4%) | |
| Avoided shortage: | 2 (1%) | |
| Resolved: | 241 (77%) | |
Discontinuation Reports |
0 |
|
| To be discontinued: | 0 | |
| Discontinued: | 0 | |
| Reversed: | 0 | |
Late reports |
21 (7%) |
|
Overdue reports |
1 (1%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACH-ATORVASTATIN CALCIUM | 40MG | TABLET | Resolved | 2024-01-19 | 2024-03-09 | 216773 |
| ACH-ATORVASTATIN CALCIUM | 80MG | TABLET | Resolved | 2022-01-21 | 2022-05-27 | 153338 |
| ACH-ATORVASTATIN CALCIUM | 80MG | TABLET | Resolved | 2022-11-25 | 2022-12-10 | 175819 |
| ACH-ATORVASTATIN CALCIUM | 80MG | TABLET | Resolved | 2023-07-07 | 2023-08-19 | 197908 |
| ACH-ATORVASTATIN CALCIUM | 80MG | TABLET | Resolved | 2023-09-01 | 2023-10-27 | 203456 |
| ACH-ATORVASTATIN CALCIUM | 80MG | TABLET | Resolved | 2024-01-19 | 2024-03-08 | 216776 |
| ACH-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-12-02 | 2022-12-19 | 177027 |
| ACH-PRAVASTATIN | 10MG | TABLET | Resolved | 2023-02-24 | 2023-03-18 | 185589 |
| ACH-PRAVASTATIN | 10MG | TABLET | Resolved | 2023-03-20 | 2023-06-30 | 187454 |
| ACH-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-05-26 | 2023-01-28 | 161340 |
| ACH-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-12-02 | 2023-08-05 | 177042 |
| METHOTREXATE SUBCUTANEOUS | 17.5MG | SOLUTION | Resolved | 2022-11-25 | 2023-06-30 | 175814 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-01-13 | 2023-01-28 | 181024 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-05-05 | 2023-05-18 | 191746 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-06-12 | 2023-06-17 | 194721 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-07-07 | 2023-07-22 | 197905 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-09-01 | 2023-10-03 | 203459 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-10-20 | 2023-10-27 | 207602 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2023-11-24 | 2024-01-19 | 211388 |
| METHOTREXATE SUBCUTANEOUS | 20MG | SOLUTION | Resolved | 2024-04-19 | 2024-05-10 | 225687 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0